Literature DB >> 10086947

Urinary excretion of pyridinium crosslinks in healthy 4-10 year olds.

S M Husain1, Z Mughal, G Williams, K Ward, C S Smith, J Dutton, W D Fraser.   

Abstract

Urinary pyridinoline and deoxypyridinoline, pyridinium crosslinks released during breakdown of mature collagen, might serve as useful markers of bone resorption. Before their role can be identified, reference values must be established. In this study, free pyridinoline (f-Pyr), free deoxypyridinoline (f-DPyr), and creatinine (Cr) were measured in first morning void urine samples from 250 girls and 265 boys between the ages of 4 and 10 years. Overall, there was a decrease in f-Pyr:Cr and f-DPyr:Cr ratios with increasing age in both sexes, but there was a wide range of values for individuals of similar ages. Further studies are required to assess whether urinary pyridinium crosslink excretion is sufficiently deranged in conditions affecting bone metabolism for the measurement of these compounds to be of clinical value.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10086947      PMCID: PMC1717887          DOI: 10.1136/adc.80.4.370

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  21 in total

Review 1.  The assessment of bone metabolism in vivo using biochemical approaches.

Authors:  R G Russell
Journal:  Horm Metab Res       Date:  1997-03       Impact factor: 2.936

2.  Biochemical markers of bone turnover in seronegative spondylarthropathy: relationship to disease activity.

Authors:  A G MacDonald; G Birkinshaw; B Durham; R C Bucknall; W D Fraser
Journal:  Br J Rheumatol       Date:  1997-01

3.  Pyridinium crosslinks of collagen as a marker of bone resorption rates in children and adolescents: normal values and clinical application.

Authors:  J Marowska; M Kobylińska; J Lukaszkiewicz; A Tałajko; B Rymkiewicz-Kluczyńska; R S Lorenc
Journal:  Bone       Date:  1996-12       Impact factor: 4.398

4.  Changes with age in the urinary excretion of hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP).

Authors:  Y Açil; J Brinckmann; H Notbohm; P K Müller; B Bätge
Journal:  Scand J Clin Lab Invest       Date:  1996-05       Impact factor: 1.713

5.  Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis.

Authors:  R Eastell; A Colwell; L Hampton; J Reeve
Journal:  J Bone Miner Res       Date:  1997-01       Impact factor: 6.741

6.  Osteocalcin, growth, and inhaled corticosteroids: a prospective study.

Authors:  I Doull; N Freezer; S Holgate
Journal:  Arch Dis Child       Date:  1996-06       Impact factor: 3.791

7.  Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate.

Authors:  N H Birkebaek; G Esberg; K Andersen; O Wolthers; C Hassager
Journal:  Arch Dis Child       Date:  1995-12       Impact factor: 3.791

8.  A comparison of the urinary excretion of bone resorptive products in white and black children.

Authors:  J H Pratt; A K Manatunga; M Peacock
Journal:  J Lab Clin Med       Date:  1996-01

9.  Urinary pyridinoline and deoxypyridinoline in healthy children and in children with growth hormone deficiency.

Authors:  S Fujimoto; T Kubo; H Tanaka; M Miura; Y Seino
Journal:  J Clin Endocrinol Metab       Date:  1995-06       Impact factor: 5.958

10.  Urinary pyridinoline and deoxypyridinoline excretion in children.

Authors:  N J Shaw; J Dutton; W D Fraser; C S Smith
Journal:  Clin Endocrinol (Oxf)       Date:  1995-06       Impact factor: 3.478

View more
  9 in total

1.  Bone mineral density and bone turnover in patients with Bartter syndrome.

Authors:  Juan Rodríguez-Soriano; Alfredo Vallo; Mireia Aguirre
Journal:  Pediatr Nephrol       Date:  2005-06-08       Impact factor: 3.714

2.  Bone alterations in children with idiopathic hypercalciuria at the time of diagnosis.

Authors:  Maria-Goretti Moreira Guimarães Penido; Eleonora Moreira Lima; Viviane Santuari Parizotto Marino; Ana-Luiza Fialho Tupinambá; Anderson França; Marcelo Ferraz Oliveira Souto
Journal:  Pediatr Nephrol       Date:  2002-12-19       Impact factor: 3.714

3.  Bone biochemical markers for assessment of bone responses to differentiated phosphorus supply in growing-finishing pigs.

Authors:  Kristina U Sørensen; Marlena C Kruger; Jens Hansen-Møller; Hanne D Poulsen
Journal:  J Anim Sci       Date:  2018-11-21       Impact factor: 3.159

4.  Serum Pyridinoline is Associated With Radiographic Joint Erosions in Rheumatoid Arthritis.

Authors:  Abu Mansor Matardiah Nor Hashimah; Rajalingham Sakthiswary; Syahrul Sazliyana Shaharir; Asrul Wahab
Journal:  Arch Rheumatol       Date:  2019-04-22       Impact factor: 1.472

5.  Decreased bone formation and increased osteoclastogenesis cause bone loss in mucolipidosis II.

Authors:  Katrin Kollmann; Jan Malte Pestka; Sonja Christin Kühn; Elisabeth Schöne; Michaela Schweizer; Kathrin Karkmann; Takanobu Otomo; Philip Catala-Lehnen; Antonio Virgilio Failla; Robert Percy Marshall; Matthias Krause; Rene Santer; Michael Amling; Thomas Braulke; Thorsten Schinke
Journal:  EMBO Mol Med       Date:  2013-10-15       Impact factor: 12.137

6.  Two cases of pseudohypoparathyroidism type ia in duozygotic twins with different phenotypes.

Authors:  Keisuke Nagasaki; Yutaka Shimomura; Takayuki Suyama; Shinichi Magara; Yohei Ogawa; Makoto Hiura; Toru Kikuchi; Makoto Uchiyama
Journal:  Clin Pediatr Endocrinol       Date:  2005-08-12

7.  The effects of short-term use of granulocyte colony-stimulating factor on bone metabolism in child cancer patients.

Authors:  Ayse Bozkurt Turhan; Cigdem Binay; Ozcan Bor; Enver Simsek
Journal:  North Clin Istanb       Date:  2018-12-03

8.  Is hematopoietic stem cell transplantation a therapeutic option for mucolipidosis type II?

Authors:  Luise Sophie Ammer; Sandra Pohl; Sandra Rafaela Breyer; Charlotte Aries; Jonas Denecke; Anna Perez; Martin Petzoldt; Johanna Schrum; Ingo Müller; Nicole Maria Muschol
Journal:  Mol Genet Metab Rep       Date:  2021-01-14

9.  Pathogenic variants in GNPTAB and GNPTG encoding distinct subunits of GlcNAc-1-phosphotransferase differentially impact bone resorption in patients with mucolipidosis type II and III.

Authors:  Giorgia Di Lorenzo; Lena M Westermann; Timur A Yorgan; Julian Stürznickel; Nataniel F Ludwig; Luise S Ammer; Anke Baranowsky; Shiva Ahmadi; Elham Pourbarkhordariesfandabadi; Sandra R Breyer; Tim N Board; Anne Foster; Jean Mercer; Karen Tylee; Renata Voltolini Velho; Michaela Schweizer; Thomas Renné; Thomas Braulke; Dévora N Randon; Fernanda Sperb-Ludwig; Louise Lapagesse de Camargo Pinto; Carolina Araujo Moreno; Denise P Cavalcanti; Michael Amling; Kerstin Kutsche; Dominic Winter; Nicole M Muschol; Ida V D Schwartz; Tim Rolvien; Tatyana Danyukova; Thorsten Schinke; Sandra Pohl
Journal:  Genet Med       Date:  2021-08-02       Impact factor: 8.822

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.